Bio equivalency tests for 199 drugs to be reviewed.

Published: 2006-09-14 06:57:00

Updated: 2006-09-14 06:57:00

The KFDA announced that about 130 drugs could be cancelled due to the bio equivalency test manipulation and other 199 drugs which were unable clearly to interpret the data (the items unable to recover its original data) should be reviewed or directed to conduct the comparative dissolution tests.

The KFDA may announce the consolidated plans related with the bio equivalency test manipulation ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.